Dongwha Pharm.Co (000020.KS) Earnings Analysis
Dongwha Pharm.Co (000020.KS) has no confirmed upcoming earnings date. Trailing P/E 7.45.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 000020.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 000020.KS. This page updates as the calendar is published.
000020.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-30 | 35 KRW | n/a | n/a | n/a |
| 2025-08-14 | 261.22 KRW | n/a | n/a | n/a |
| 2025-05-15 | 2.48 KRW | n/a | n/a | n/a |
| 2025-02-24 | -23.08189 KRW | n/a | n/a | n/a |
| 2024-08-14 | 127.09 KRW | n/a | n/a | n/a |
000020.KS valuation and analyst view
| Trailing P/E | 7.45 |
|---|---|
| Trailing EPS | 673.61 KRW |
| Price / book | 0.36 |
| Dividend yield | 4.88% |
| Market cap | 136.10B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Dongwha Pharm.Co (000020.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 000020.KS. This page updates as the calendar is published.
Did 000020.KS beat earnings last quarter?
Consensus estimate data was not available for 000020.KS's 2025-09-30 report.
What is 000020.KS's current P/E ratio and EPS?
000020.KS trades at a trailing P/E of 7.45 on trailing EPS of 673.605849267624 KRW.
What do analysts rate 000020.KS?
000020.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.